admin

PPMA appreciates the Finance Minister’s recognition and remains committed to strengthening public–private partnerships for a healthier, self-reliant Pakistan.

The Pakistan Pharmaceutical Industry is uniquely positioned to address this national pain point. With promising reforms, digital transformation, and investment support, the industry is on a strong growth path. Public-private partnerships and research-driven models offer new hope for both patients and producers. Moreover, the Pakistan Pharmaceutical Manufacturers Association (PPMA) serves as a key body in

Understanding the Pharmaceutical Industry begins with recognizing a key concern—millions still lack access to essential medicines. Despite global advancements, supply chain issues, regulatory gaps, and rising costs create barriers to treatment. However, with coordinated efforts and reforms, the industry holds immense potential to close these gaps. Collaboration between governments, researchers, and bodies like the Pakistan

Understanding the Pharmaceutical Industry begins with recognizing the increasing global demand for affordable medicine. Millions worldwide still lack timely access to essential treatments, creating an urgent need for scalable solutions. However, with digital innovation, strategic policy shifts, and global collaboration, the sector is poised for transformative growth. Organizations such as the Pakistan Pharmaceutical Manufacturers Association